E Fund Hang Seng Hong Kong Stock Connect Innovative Drugs ETF (SHE:159316)
China · Delayed Price · Currency is CNY 1.135
+0.018 (1.61%)
At close: May 21, 2026
4.51% (1Y)
| Assets | 5.00B |
| Expense Ratio | n/a |
| PE Ratio | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +4.51% |
| Volume | 748,484,300 |
| Open | 1.127 |
| Previous Close | 1.117 |
| Day's Range | 1.125 - 1.152 |
| 52-Week Low | 1.053 |
| 52-Week High | 1.715 |
| Beta | n/a |
| Holdings | n/a |
| Inception Date | Mar 18, 2025 |
About 159316
159316.SZ was created on 2025-03-18 by E Fund . The fund's investment portfolio concentrates primarily on health care equity.
Asset Class Equity
Category Health Care
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 159316
Provider E Fund
Index Tracked CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net
Performance
159316 had a total return of 4.51% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.65%.